Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 55/100

Failure Rate

25.0%

1 terminated/withdrawn out of 4 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

100%

1 of 1 completed trials have results

Key Signals

1 recruiting1 with results

Enrollment Performance

Analytics

N/A
3(75.0%)
Phase 4
1(25.0%)
4Total
N/A(3)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06489873Not ApplicableRecruiting

Lutein, Zeaxathin, and Fish Oil Supplementation

Role: collaborator

NCT03458494Not ApplicableTerminated

The TCF7L2 Gene: Dietary Prevention of T2DM

Role: collaborator

NCT01576783Phase 4Completed

Omega Tots: A Randomized, Controlled Trial of Long-chain Polyunsaturated Fatty Acid Supplementation of Toddler Diets and Developmental Outcomes

Role: collaborator

NCT02397304Not ApplicableUnknown

Nutrition, Exercise and Muscle Metabolism in Obesity

Role: collaborator

All 4 trials loaded